ECSP034558A - Moduladores del receptor estrogeno - Google Patents
Moduladores del receptor estrogenoInfo
- Publication number
- ECSP034558A ECSP034558A EC2003004558A ECSP034558A ECSP034558A EC SP034558 A ECSP034558 A EC SP034558A EC 2003004558 A EC2003004558 A EC 2003004558A EC SP034558 A ECSP034558 A EC SP034558A EC SP034558 A ECSP034558 A EC SP034558A
- Authority
- EC
- Ecuador
- Prior art keywords
- strogen
- receiver modulators
- modulators
- receiver
- graph
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24158200P | 2000-10-19 | 2000-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP034558A true ECSP034558A (es) | 2003-06-25 |
Family
ID=22911282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2003004558A ECSP034558A (es) | 2000-10-19 | 2003-04-17 | Moduladores del receptor estrogeno |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1333827A2 (fr) |
| JP (1) | JP2004511502A (fr) |
| KR (1) | KR20030042020A (fr) |
| CN (1) | CN1469743A (fr) |
| AU (2) | AU2002232381B2 (fr) |
| BG (1) | BG107676A (fr) |
| BR (1) | BR0114689A (fr) |
| CA (1) | CA2424729A1 (fr) |
| EA (1) | EA200300474A1 (fr) |
| EC (1) | ECSP034558A (fr) |
| EE (1) | EE200300153A (fr) |
| HU (1) | HUP0303563A2 (fr) |
| IL (1) | IL154984A0 (fr) |
| IS (1) | IS6761A (fr) |
| MX (1) | MXPA03003485A (fr) |
| NO (1) | NO20031737L (fr) |
| PE (1) | PE20021083A1 (fr) |
| PL (1) | PL361053A1 (fr) |
| SK (1) | SK4772003A3 (fr) |
| WO (1) | WO2002032377A2 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030225132A1 (en) * | 2002-04-11 | 2003-12-04 | Dininno Frank P. | Estrogen receptor modulators |
| WO2003091239A1 (fr) | 2002-04-24 | 2003-11-06 | Merck & Co., Inc. | Modulateurs de recepteurs d'oestrogene |
| JP4500689B2 (ja) * | 2002-12-26 | 2010-07-14 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 選択的エストロゲン受容体モジュレーター |
| KR101431279B1 (ko) * | 2005-07-29 | 2014-08-20 | 리스버로직스 코퍼레이션 | 복합 질환의 예방 및 치료용 약학적 조성물 및 삽입가능한의료 장치에 의한 이의 전달 |
| JPWO2007049798A1 (ja) * | 2005-10-27 | 2009-04-30 | 萬有製薬株式会社 | 新規ベンゾオキサチイン誘導体 |
| PL2118074T3 (pl) | 2007-02-01 | 2014-06-30 | Resverlogix Corp | Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego |
| ES2463097T3 (es) | 2009-01-08 | 2014-05-27 | Resverlogix Corp. | Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares |
| US9238640B2 (en) | 2009-03-18 | 2016-01-19 | Resverlogix Corp. | Anti-inflammatory agents |
| NZ596117A (en) | 2009-04-22 | 2014-10-31 | Resverlogix Corp | Novel anti-inflammatory agents |
| EP3205648A1 (fr) | 2010-06-10 | 2017-08-16 | Seragon Pharmaceuticals, Inc. | Modulateur du récepteur oestrogénique et utilisation de ces derniers |
| WO2011159769A2 (fr) | 2010-06-17 | 2011-12-22 | Aragon Pharmaceuticals, Inc. | Modulateurs de récepteur d'œstrogène d'indane et utilisations de ceux-ci |
| HUE044986T2 (hu) | 2011-11-01 | 2019-11-28 | Resverlogix Corp | Orális, azonnali felszabadulású készítmények szubsztituált kinazolinonokhoz |
| EA029559B1 (ru) | 2011-12-14 | 2018-04-30 | Серагон Фармасьютикалс, Инк. | Фторированные модуляторы рецепторов эстрогенов и их применение |
| WO2014080290A2 (fr) | 2012-11-21 | 2014-05-30 | Rvx Therapeutics Inc. | Amines cycliques servant d'inhibiteurs de bromodomaines |
| US9765039B2 (en) | 2012-11-21 | 2017-09-19 | Zenith Epigenetics Ltd. | Biaryl derivatives as bromodomain inhibitors |
| KR20150096794A (ko) | 2012-12-21 | 2015-08-25 | 제니쓰 에피제네틱스 코포레이션 | 브로모도메인 저해제로서의 신규한 헤테로사이클릭 화합물 |
| CN114984016A (zh) | 2015-03-13 | 2022-09-02 | 雷斯韦洛吉克斯公司 | 用于治疗补体相关疾病之组合物及治疗方法 |
-
2001
- 2001-10-15 EE EEP200300153A patent/EE200300153A/xx unknown
- 2001-10-15 CN CNA018176720A patent/CN1469743A/zh active Pending
- 2001-10-15 MX MXPA03003485A patent/MXPA03003485A/es unknown
- 2001-10-15 SK SK477-2003A patent/SK4772003A3/sk unknown
- 2001-10-15 EA EA200300474A patent/EA200300474A1/ru unknown
- 2001-10-15 EP EP01987654A patent/EP1333827A2/fr not_active Withdrawn
- 2001-10-15 KR KR10-2003-7005518A patent/KR20030042020A/ko not_active Application Discontinuation
- 2001-10-15 JP JP2002535616A patent/JP2004511502A/ja not_active Withdrawn
- 2001-10-15 AU AU2002232381A patent/AU2002232381B2/en not_active Ceased
- 2001-10-15 IL IL15498401A patent/IL154984A0/xx unknown
- 2001-10-15 BR BR0114689-0A patent/BR0114689A/pt not_active Application Discontinuation
- 2001-10-15 WO PCT/US2001/042735 patent/WO2002032377A2/fr not_active Application Discontinuation
- 2001-10-15 CA CA002424729A patent/CA2424729A1/fr not_active Abandoned
- 2001-10-15 PL PL01361053A patent/PL361053A1/xx not_active Application Discontinuation
- 2001-10-15 AU AU3238102A patent/AU3238102A/xx active Pending
- 2001-10-15 HU HU0303563A patent/HUP0303563A2/hu unknown
-
2002
- 2002-04-15 PE PE2002000308A patent/PE20021083A1/es not_active Application Discontinuation
-
2003
- 2003-03-26 BG BG107676A patent/BG107676A/bg unknown
- 2003-03-27 IS IS6761A patent/IS6761A/is unknown
- 2003-04-15 NO NO20031737A patent/NO20031737L/no unknown
- 2003-04-17 EC EC2003004558A patent/ECSP034558A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20031737D0 (no) | 2003-04-15 |
| IL154984A0 (en) | 2003-10-31 |
| WO2002032377A3 (fr) | 2002-08-22 |
| KR20030042020A (ko) | 2003-05-27 |
| SK4772003A3 (en) | 2003-08-05 |
| PE20021083A1 (es) | 2002-12-16 |
| EE200300153A (et) | 2003-06-16 |
| PL361053A1 (en) | 2004-09-20 |
| HUP0303563A2 (hu) | 2004-03-01 |
| AU2002232381B2 (en) | 2004-11-18 |
| IS6761A (is) | 2003-03-27 |
| BG107676A (bg) | 2003-11-28 |
| EA200300474A1 (ru) | 2003-10-30 |
| AU3238102A (en) | 2002-04-29 |
| NO20031737L (no) | 2003-06-19 |
| BR0114689A (pt) | 2003-07-01 |
| WO2002032377A2 (fr) | 2002-04-25 |
| EP1333827A2 (fr) | 2003-08-13 |
| MXPA03003485A (es) | 2003-07-14 |
| JP2004511502A (ja) | 2004-04-15 |
| CN1469743A (zh) | 2004-01-21 |
| CA2424729A1 (fr) | 2002-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP034558A (es) | Moduladores del receptor estrogeno | |
| DOP2001000151A (es) | Derivados de imidazopirimidina y derivados de triazolopimidina. | |
| DE69907977D1 (de) | Pyrrolobenzodiazepine | |
| ECSP034600A (es) | Compuestos de lactama | |
| TR200202194T2 (tr) | Poliglütamik asit-kamptotesin birleşikleri ve hazırlama yöntemleri | |
| ECSP045245A (es) | N-aril-2-oxazolidinona-5-carboxamidas y sus derivados | |
| DE60135919D1 (de) | Farnesyl transferase-hemmende 6-heterocyclylmethyl-chinolin und chinazol-derivate | |
| PA8522701A1 (es) | COMPUESTOS DE ACETAMIDAS BENCENICAS QUE SON ACTIVADORES DE LA GLUCOKINASA a-ACILO-Y a-HETEROATOMO-SUSTITUIDO | |
| ECSP024382A (es) | Inhibidores de proteasa de serina | |
| PA8567001A1 (es) | Composicion de ziprasidona y controles sinteticos | |
| PE20020108A1 (es) | Estructuras y composiciones que aumentan la estabilidad de activos de peroxido | |
| JO2410B1 (en) | 6. Replaced pyrido-pyrimidines | |
| ES2189657B1 (es) | Composiciones de resina plaguicidas. | |
| PA8553101A1 (es) | Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion | |
| UY27250A1 (es) | Fenil-heterociclil-cteres | |
| HN2002000235A (es) | Formulaciones en combinacion de derivados de 1, 4 - benzotiepina - 1, 1 - dioxido con otras sustancias activas, y su utilización | |
| RS50002B (sr) | Eletriptan hidrobromid monohidrat | |
| MY128164A (en) | Compounds | |
| SV2003001179A (es) | Formulacion de 2-metilo-tieno-benzodiacepina liofilizada ref. x-11102 | |
| BG105964A (en) | C(10) carbonate substituted taxanes and their use as antitumor agents | |
| BR0114065A (pt) | Triazolo-epotilonas | |
| ATE401325T1 (de) | C10-carbamoyloxysubstituierte taxane als antitumormittel | |
| IL145643A0 (en) | C7 carbamoyloxy substituted taxanes as antitumor agents | |
| BR0313400A (pt) | N-aril-2-oxazolidinonas e seus derivados | |
| DOP2000000050A (es) | Composición antidecoloracion |